| Dr Renee Sue Reinholdt, OD | |
|
1495 S Black Ridge Dr, Suite A270, Saint George, UT 84770-5622 | |
| (435) 628-9100 | |
| (877) 591-6983 |
| Full Name | Dr Renee Sue Reinholdt |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 34 Years |
| Location | 1495 S Black Ridge Dr, Saint George, Utah |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558404194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 18003272A (Indiana) | Secondary |
| 152W00000X | Optometrist | 8516710-9934 (Utah) | Primary |
| 152W00000X | Optometrist | 900 (Nevada) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Renee Sue Reinholdt, OD 4985 N Mesquite Dr, Saint George, UT 84770-5442 Ph: (317) 590-5372 | Dr Renee Sue Reinholdt, OD 1495 S Black Ridge Dr, Suite A270, Saint George, UT 84770-5622 Ph: (435) 628-9100 |
News Archive
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
› Verified 4 days ago
St George Eye Center Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1054 E Riverside Dr, 201, Saint George, UT 84790 Phone: 435-628-4507 Fax: 435-628-3748 | |
Dr. Jeffery Donald Graf, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 754 S Main St, Ste 6, Saint George, UT 84770 Phone: 435-634-0420 Fax: 435-634-5409 | |
Andrus Vision Center Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 803 S Bluff St, Saint George, UT 84770 Phone: 435-628-4464 Fax: 435-628-5015 | |
Vision Care 20/20, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 East 100 South, Saint George, UT 84770 Phone: 702-481-1074 | |
Dr. Eric Dennis Drake, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 965 E 700 S Ste 100, Saint George, UT 84790 Phone: 435-673-5577 | |
Christopher Rae Wood, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 749 S River Rd, Saint George, UT 84790 Phone: 435-628-4464 | |
Graf Medical Eye Care And Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 754 S Main St, Ste 6, Saint George, UT 84770 Phone: 435-634-0420 Fax: 435-634-5409 |